InvestorsHub Logo
Followers 12
Posts 2377
Boards Moderated 0
Alias Born 01/23/2006

Re: DewDiligence post# 195201

Monday, 10/27/2014 7:00:09 PM

Monday, October 27, 2014 7:00:09 PM

Post# of 346050
Dew..since the patients would still be taking a regular dose of Docetaxel for second line (as the SOC), why wouldn't they or their doctors be interested in entering this trial with the possibility that an additional molecule, with a well-known safety profile, MAY boost it's effectiveness?

how did you come up with your ratio?

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News